Search

Author/Creator Hospital, Mercedes

1. A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg. Issue 4 (29th June 2020)

Authors:
Llamas‐Velasco, Mar; Baniandrés, Ofelia; Rivera, Raquel; Reymundo Jimenez, Ana; Hospital, Mercedes; García Zamora, Elena; González‐Cantero, Álvaro; Andrés Lencina, Juan‐José; Daudén, Esteban; de la Cueva, Pablo
Journal:
Dermatologic therapy
Issue:
Volume 33:Issue 4(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Risankizumab in psoriasis: prior biologics failure does not impact on short-term effectiveness. (2nd January 2022)

Authors:
Rivera-Díaz, Raquel; LLamas-Velasco, Mar; Hospital, Mercedes; Martín, Isabel; Baniandrés, Ofelia; Ruíz-Genao, Diana; de la Cueva, Pablo; García-Donoso, Carmen
Journal:
Expert opinion on biological therapy
Issue:
Volume 22:Number 1(2022)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life. Issue 10 (18th August 2022)

Authors:
Berenguer‐Ruiz, Sonsoles; Rivera, Raquel; Herranz, Pedro; De la Cueva, Pablo; Hospital, Mercedes; Ruiz‐Genao, Diana; Roustan, Gastón; Daudén, Esteban; Llamas‐Velasco, Mar
Journal:
Dermatologic therapy
Issue:
Volume 35:Issue 10(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗